✦ LIBER ✦

58 Pulmonary exacerbations in CF patients with the G551D-CFTR mutation treated with ivacaftor

✍ Scribed by Flume, P.; Wainwright, C.; Tullis, E.; Rodriguez, S.; Davies, J.; Wagener, J.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

44 Pulmonary exacerbations in a Phase 3

✍ M. Griese; B. Ramsey; S. Rodriguez; K. Yen; J.S. Elborn 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 68 KB

43 Patient-reported outcomes in Phase 3

✍ A.L. Quittner; B. Ramsey; Q. Dong; K. Yen; J.S. Elborn 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 67 KB

WS3.1 The effect of ivacaftor on the rat

✍ Sawicki, G.S.; McKone, E.; Pasta, D.J.; Wagener, J.; Johnson, C.; Konstan, M.W. 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 67 KB

WS10.3 Adherence with ivacaftor in cysti

✍ Fox, J.; Jones, G.H.; Sapina-Vivo, R.; Phitidis, E.; Ledson, M.; Walshaw, M.; Gr 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 57 KB

53 Lung function, weight, and sweat chlo

✍ Plant, B.J.; Konstan, M.; Aherns, R.; Rodriguez, S.; Munck, A.; Elborn, J.S.; Jo 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 73 KB

WS23.3 ICM is sensitive to detect potent

✍ Graeber, S.Y.; Hug, M.J.; Sommerburg, O.; Mainz, J.G.; Heinzmann, A.; Tümmler, B 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 61 KB